These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 7721952)
1. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence. Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. Funk SE; Sage EH J Cell Physiol; 1993 Jan; 154(1):53-63. PubMed ID: 8419407 [TBL] [Abstract][Full Text] [Related]
3. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand. Murphy-Ullrich JE; Lane TF; Pallero MA; Sage EH J Cell Biochem; 1995 Feb; 57(2):341-50. PubMed ID: 7539008 [TBL] [Abstract][Full Text] [Related]
4. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. Hasselaar P; Sage EH J Cell Biochem; 1992 Jul; 49(3):272-83. PubMed ID: 1644864 [TBL] [Abstract][Full Text] [Related]
5. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Funk SE; Sage EH Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2648-52. PubMed ID: 2011576 [TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC. Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265 [TBL] [Abstract][Full Text] [Related]
7. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. Vogel T; Guo NH; Krutzsch HC; Blake DA; Hartman J; Mendelovitz S; Panet A; Roberts DD J Cell Biochem; 1993 Sep; 53(1):74-84. PubMed ID: 8227183 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. Vogel T; Guo NH; Guy R; Drezlich N; Krutzsch HC; Blake DA; Panet A; Roberts DD J Cell Biochem; 1994 Mar; 54(3):299-308. PubMed ID: 8200910 [TBL] [Abstract][Full Text] [Related]
10. Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. Presta M; Rusnati M; Urbinati C; Sommer A; Ragnotti G J Cell Physiol; 1991 Dec; 149(3):512-24. PubMed ID: 1660485 [TBL] [Abstract][Full Text] [Related]
11. The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. Maurer P; Hohenadl C; Hohenester E; Göhring W; Timpl R; Engel J J Mol Biol; 1995 Oct; 253(2):347-57. PubMed ID: 7563094 [TBL] [Abstract][Full Text] [Related]
12. Changes in calcium and collagen IV binding caused by mutations in the EF hand and other domains of extracellular matrix protein BM-40 (SPARC, osteonectin). Pottgiesser J; Maurer P; Mayer U; Nischt R; Mann K; Timpl R; Krieg T; Engel J J Mol Biol; 1994 May; 238(4):563-74. PubMed ID: 8176746 [TBL] [Abstract][Full Text] [Related]
13. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling. Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314 [TBL] [Abstract][Full Text] [Related]
14. Effects of basic fibroblast growth factor on proliferation, the expression of osteonectin (SPARC) and alkaline phosphatase, and calcification in cultures of human pulp cells. Shiba H; Nakamura S; Shirakawa M; Nakanishi K; Okamoto H; Satakeda H; Noshiro M; Kamihagi K; Katayama M; Kato Y Dev Biol; 1995 Aug; 170(2):457-66. PubMed ID: 7649376 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Iruela-Arispe ML; Hasselaar P; Sage H Lab Invest; 1991 Feb; 64(2):174-86. PubMed ID: 1705300 [TBL] [Abstract][Full Text] [Related]
16. Purification of biologically active SPARC expressed in Saccharomyces cerevisiae. Yost JC; Bell A; Seale R; Sage EH Arch Biochem Biophys; 1994 Oct; 314(1):50-63. PubMed ID: 7944407 [TBL] [Abstract][Full Text] [Related]
17. The C-terminal Ca2+-binding domain of SPARC confers anti-spreading activity to human urothelial cells. Delostrinos CF; Hudson AE; Feng WC; Kosman J; Bassuk JA J Cell Physiol; 2006 Jan; 206(1):211-20. PubMed ID: 16121393 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture. Shiba H; Fujita T; Doi N; Nakamura S; Nakanishi K; Takemoto T; Hino T; Noshiro M; Kawamoto T; Kurihara H; Kato Y J Cell Physiol; 1998 Feb; 174(2):194-205. PubMed ID: 9428806 [TBL] [Abstract][Full Text] [Related]
19. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine. Basu A; Rodeck U; Prendergast GC; Howe CC Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40. Hohenester E; Maurer P; Timpl R EMBO J; 1997 Jul; 16(13):3778-86. PubMed ID: 9233787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]